These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 24418683)
1. First-morning urinary melatonin and breast cancer risk in the Guernsey Study. Wang XS; Tipper S; Appleby PN; Allen NE; Key TJ; Travis RC Am J Epidemiol; 2014 Mar; 179(5):584-93. PubMed ID: 24418683 [TBL] [Abstract][Full Text] [Related]
2. Melatonin and breast cancer: a prospective study. Travis RC; Allen DS; Fentiman IS; Key TJ J Natl Cancer Inst; 2004 Mar; 96(6):475-82. PubMed ID: 15026473 [TBL] [Abstract][Full Text] [Related]
3. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. Schernhammer ES; Berrino F; Krogh V; Secreto G; Micheli A; Venturelli E; Sieri S; Sempos CT; Cavalleri A; Schünemann HJ; Strano S; Muti P J Natl Cancer Inst; 2008 Jun; 100(12):898-905. PubMed ID: 18544743 [TBL] [Abstract][Full Text] [Related]
4. Urinary Melatonin in Relation to Breast Cancer Risk: Nested Case-Control Analysis in the DOM Study and Meta-analysis of Prospective Studies. Wong ATY; Fensom GK; Key TJ; Onland-Moret NC; Tong TYN; Travis RC Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):97-103. PubMed ID: 33144281 [TBL] [Abstract][Full Text] [Related]
5. Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore. Wu AH; Stanczyk FZ; Wang R; Koh WP; Yuan JM; Yu MC Int J Cancer; 2013 Feb; 132(4):891-6. PubMed ID: 22644618 [TBL] [Abstract][Full Text] [Related]
6. Urinary levels of melatonin and risk of postmenopausal breast cancer: women's health initiative observational cohort. Sturgeon SR; Doherty A; Reeves KW; Bigelow C; Stanczyk FZ; Ockene JK; Liu S; Manson JE; Neuhouser ML Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):629-37. PubMed ID: 24510738 [TBL] [Abstract][Full Text] [Related]
7. Urinary melatonin concentration and the risk of breast cancer in Nurses' Health Study II. Brown SB; Hankinson SE; Eliassen AH; Reeves KW; Qian J; Arcaro KF; Wegrzyn LR; Willett WC; Schernhammer ES Am J Epidemiol; 2015 Feb; 181(3):155-62. PubMed ID: 25587174 [TBL] [Abstract][Full Text] [Related]
8. Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort. Schernhammer ES; Hankinson SE Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):74-9. PubMed ID: 19124483 [TBL] [Abstract][Full Text] [Related]
9. Urinary melatonin and risk of ovarian cancer. Poole EM; Schernhammer E; Mills L; Hankinson SE; Tworoger SS Cancer Causes Control; 2015 Oct; 26(10):1501-6. PubMed ID: 26223889 [TBL] [Abstract][Full Text] [Related]
10. Urinary Melatonin in Relation to Postmenopausal Breast Cancer Risk According to Melatonin 1 Receptor Status. Devore EE; Warner ET; Eliassen AH; Brown SB; Beck AH; Hankinson SE; Schernhammer ES Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):413-419. PubMed ID: 28151704 [No Abstract] [Full Text] [Related]
11. Urinary melatonin levels and breast cancer risk. Schernhammer ES; Hankinson SE J Natl Cancer Inst; 2005 Jul; 97(14):1084-7. PubMed ID: 16030307 [TBL] [Abstract][Full Text] [Related]
12. A nested case-control study of the association between melatonin secretion and incident myocardial infarction. McMullan CJ; Rimm EB; Schernhammer ES; Forman JP Heart; 2017 May; 103(9):694-701. PubMed ID: 27806988 [TBL] [Abstract][Full Text] [Related]
13. Sleep duration, nightshift work, and the timing of meals and urinary levels of 8-isoprostane and 6-sulfatoxymelatonin in Japanese women. Nagata C; Tamura T; Wada K; Konishi K; Goto Y; Nagao Y; Ishihara K; Yamamoto S Chronobiol Int; 2017; 34(9):1187-1196. PubMed ID: 28933565 [TBL] [Abstract][Full Text] [Related]
14. Association of nocturnal melatonin secretion with insulin resistance in nondiabetic young women. McMullan CJ; Curhan GC; Schernhammer ES; Forman JP Am J Epidemiol; 2013 Jul; 178(2):231-8. PubMed ID: 23813704 [TBL] [Abstract][Full Text] [Related]
15. Associations between nocturnal urinary 6-sulfatoxymelatonin, obstructive sleep apnea severity and glycemic control in type 2 diabetes. Reutrakul S; Siwasaranond N; Nimitphong H; Saetung S; Chirakalwasan N; Chailurkit LO; Srijaruskul K; Ongphiphadhanakul B; Thakkinstian A Chronobiol Int; 2017; 34(3):382-392. PubMed ID: 28128991 [TBL] [Abstract][Full Text] [Related]
16. Disruption of sleep, sleep-wake activity rhythm, and nocturnal melatonin production in breast cancer patients undergoing adjuvant chemotherapy: prospective cohort study. Li W; Kwok CC; Chan DC; Ho AW; Ho CS; Zhang J; Wing YK; Wang F; Tse LA Sleep Med; 2019 Mar; 55():14-21. PubMed ID: 30743205 [TBL] [Abstract][Full Text] [Related]
17. Association of urinary levels of 6-sulfatoxymelatonin (aMT6s) with prevalent and incident hypertension. Pérez-Caraballo AM; Ma Y; Ockene JK; Reeves KW; Balasubramanian R; Stanczyk FZ; Allison MA; Chen C; Wang L; Manson JE; Sturgeon SR Chronobiol Int; 2018 Aug; 35(8):1115-1121. PubMed ID: 29750588 [TBL] [Abstract][Full Text] [Related]
18. Melatonin secretion and the incidence of type 2 diabetes. McMullan CJ; Schernhammer ES; Rimm EB; Hu FB; Forman JP JAMA; 2013 Apr; 309(13):1388-96. PubMed ID: 23549584 [TBL] [Abstract][Full Text] [Related]